Concordia Healthcare Corp. (NASDAQ:CXRX)’s share price dropped 3.6% on Friday . The stock traded as low as $9.18 and last traded at $9.20, with a volume of 330,778 shares changing hands. The stock had previously closed at $9.54.

CXRX has been the subject of several research reports. Zacks Investment Research raised Concordia Healthcare Corp. from a “hold” rating to a “buy” rating and set a $23.00 price objective for the company in a report on Wednesday, July 13th. TD Securities reissued a “buy” rating and set a $37.00 price objective (down from $45.00) on shares of Concordia Healthcare Corp. in a report on Wednesday, June 29th. Canaccord Genuity reissued a “buy” rating on shares of Concordia Healthcare Corp. in a report on Sunday, June 26th. Finally, GMP Securities lowered Concordia Healthcare Corp. from a “buy” rating to a “hold” rating in a report on Monday, August 15th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and eight have given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus target price of $39.72.

The stock has a 50 day moving average price of $17.21 and a 200 day moving average price of $24.83. The firm’s market cap is $469.36 million.

Concordia Healthcare Corp. (NASDAQ:CXRX) last announced its quarterly earnings data on Friday, August 12th. The company reported $1.38 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.38. The firm earned $231.70 million during the quarter, compared to analysts’ expectations of $229.76 million. The business’s quarterly revenue was up 208.1% on a year-over-year basis. Analysts expect that Concordia Healthcare Corp. will post $5.35 EPS for the current fiscal year.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.